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Introduction Repeated ischemic preconditioning (IPC) can improve muscle and pulmonary 
oxygen on-kinetics, blood flow and exercise efficiency but these effects have not been 
investigated severe hypoxia.  The aim of the current study was to evaluate the effects of 7 d 
of IPC on resting and exercising muscle and cardio-pulmonary responses to severe hypoxia. 
Methods Fourteen subjects received either: 1) 7 d of repeated lower-limb occlusion (4 x 5 
min, 217±30 mm Hg) at limb occlusive pressure (IPC) or SHAM (4 x 5 min, 20 mm Hg). 
Subjects were tested for resting limb blood flow (72), relative microvascular 
deoxyhemoglobin concentration ([HHB]) and pulmonary oxygen (V O2p) responses to steady 
state and incremental exercise to exhaustion in hypoxia (fractional inspired O2 = 0.103), 
which was followed by 7 d of IPC or SHAM, and retesting 72 h post intervention. Results 
There were no effects of IPC on maximal oxygen consumption, time to exhaustion during the 
incremental test or minute ventilation and arterial oxygen saturation. However, the IPC group 
had higher delta efficiency based on pooled results and lower steady state delta[HHB] (IPC 
~24% vs. SHAM ~6% pre-to-post), as well as slowing the [HHB] time constant (IPC ~26% 
vs. SHAM ~3% pre-to-post) and reducing the overshoot in [HHB]:V O2 ratio during exercise 
onset. Conclusions Collectively, these results demonstrate that muscle O2 efficiency and 
microvascular O2 distribution can be improved by repeated IPC but there are no effects on 
maximal exercise capacity in a severe hypoxia. 
  






Reductions in atmospheric pressure, as encountered at high-altitude, or simulated fractions of 
inspired oxygen (FiO2) lead to corresponding reductions in the partial pressure of oxygen in 
the atmospheric and, thus, inspired air. 12 These changes perturb the O2 transport cascade, 
which can often reduce arterial oxygen content, 4 impairing exercise capacity and maximal 
oxygen consumption (V O2max). 3, 42 However, the reported reductions in arterial oxygen 
content in response to severe hypoxia cannot fully explain the observed reduction in V O2max. 
Thus, reduced cardiac output ( ) and skeletal muscle blood flow are the most commonly 
ascribed factors that contribute to reduced V O2max. 2 Furthermore, the reduced pulmonary 
diffusion gradient also acutely disrupts the on-transient pulmonary V O2 and muscle 
microvascular response to moderate-intensity exercise, such that mismatches in O2 delivery 
and utilization have been reported. 39, 46 The O2 delivery–V O2 matching is vital in setting 
blood–myocyte PO2, thus directly influencing oxidative metabolic regulation. 23 These factors 
limit exercise capacity at altitude but could feasibly be attenuated by targeted training 
interventions.  
 
Given that many occupations (i.e. military, emergency services and sport) might require their 
personnel to perform physical tasks in hypoxic conditions, such as that experienced at high-
altitude, it is important that the efficacy of practical, time and cost effective strategies are 
investigated to help prepare for exercise in hypoxic environments.  For example, ischemic 
preconditioning (IPC) can enhance endurance exercise performance in normoxia 8, 19, 22 and 
hypoxia (FiO2 ~0.12-0.16). 7, 10, 33 This includes ~13% increases in peak V O2 following 1 wk 
of repeated IPC. 24 While acute pre exercise IPC interventions have been reported to enhance 
lower limb oxygenation in hypoxia 7 and might partly support the ergogenic effect, 
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contradictory evidence has been presented. 11 ,16 ,43 These inconsistent findings could relate to 
the mode of IPC, with repeated IPC (consecutive daily interventions) eliciting the greatest 
effect on limb blood flow, muscle oxidative capacity and subsequent normoxic endurance 
performance. 19 ,20 ,21 The most apparent physiological and ergogenic effects on running 
performance (~ 7 %) have been reported following repeated IPC (5 d) at higher outdoor 
altitudes (3560 m - 4342 m; ~ FiO2 ~ 0.13–0.12, respectively); 10 however, the study was 
unavoidably limited in its exercising measurements, owing to the outdoor testing 
environment and the chronic IPC adaptation window was not strictly investigated.  
 
The lack of attention towards repeated IPC and hypoxic exercise tolerance is surprising, 
given the common physical challenges that take place under these conditions 28, 38 and the 
dose dependent evidence presented in both clinical 21, 44 and performance domains. 19, 20, 24 
The adaptations conferred by IPC would be advantageous to offset the deleterious effects of 
hypoxia on oxidative capacity and efficiency 17 and could preferentially adjust the transient 
muscle microvascular O2 distribution limitation observed in hypoxic exercise. 39 The most 
recent findings demonstrate that 7 d of remote IPC enhances delta efficiency and muscle 
microvascular O2 extraction, leading to improved exercise tolerance in normoxia. Indeed, our 
research group has also demonstrated increased DE following 5-days IPC combined with heat 
acclimation 41, which is an indication of muscle efficiency. 6 DE examines the global 
relationship between metabolic rate and external power across increasing intensities, and is 
less likely to be affected by changes in baseline metabolic processes 9. Furthermore, based on 
the tightly coupled relationship reported between phase II pulmonary V O2 kinetics (the time 
constant of V O2 from rest to exercise) and the matching of O2 delivery–V O2 39 and the 
capacity to enhance these parameters with physical training 31, it would be logical that 
collective improvements in these parameters would occur alongside faster pulmonary on-
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kinetics. This could also enhance exercise tolerance via reductions in the slow component, 
which should theoretically grow in importance as the exercise duration or intensity increases. 
30 Therefore, the aim of the current study was to evaluate the effects of repeated daily IPC (7 
d) conducted in normoxic environments, on resting and exercising muscle and cardio-
pulmonary responses to severe hypoxia (FiO2 ~ 0.103). We hypothesized that repeated IPC 
would enhance the muscle microvascular and pulmonary V O2 kinetic response and exercise 




Fourteen recreationally-trained males, who were familiar with laboratory based exercise (age, 
26±4 y; stature, 181±7 cm; body mass, 83.1±12.0 kg; BMI 24.9±1.6) were recruited. Table I 
demonstrates baseline subject characteristics by group and t-tests showed no differences 
between groups. A sample size of 6 per group was calculated using G*Power (Version 
3.1.9.3), according to reductions in exercising delta dexoyhemoglobin concentration 
(∆[HHB]) post 7 d repeated IPC intervention (d = 1.64; ‘Large’). 19 Accordingly, 7 subjects 
were recruited in each group to account for potential attrition, although no subjects dropped 
out of the study. Subjects were non-smokers and had not spent any time at altitude > 1000 m 
in the past 6 months. Institutional ethical approval was provided by St Mary’s University 
ethics committee, which was conducted in accordance with the 2013 Helsinki declaration. 
 





Subjects were block randomized into 1 of 2 equal groups: either 7 consecutive days of IPC or 
SHAM intervention. As demonstrated in Figure 1, subjects visited the laboratory for baseline 
testing, followed by 7 consecutive intervention visits and 1 post testing visit, which occurred 
72 h after the final intervention (9 visits over 15 d). The 72-h time period post-intervention 
was used as this is outside the reported early and late phases of protection conferred by IPC 26 
and, therefore, would reflect a sustained adaptation to the IPC stimulus. The pre and post tests 
comprised a brief pre exercise assessment of limb blood flow, followed by steady state 
cycling (mechanical power output of 100 W) at moderate exercise intensities in a hypoxic 
environmental chamber, simulating high altitude (FiO2 = 0.103; simulated altitude ~ 5750 
m), which was temperature and humidity controlled (18 °C, 40% Relative Humidity [RH]). 
This was followed by an immediate transition into an incremental ramp test to exhaustion. 
This FiO2 was chosen as it ensured that simulated conditions were a similar severity to the 
most comparable repeated IPC study (0.12-0.13 FiO2), 10 and lower than the level shown to 
impair muscle and pulmonary kinetics (0.15 FiO2). 39, 46 
 
***Insert fig 1 here*** 
 
Procedure 
A NIRS optode (Portamon, Artinis Medical Systems, Zetten, The Netherlands) was fitted to 
the medial gastrocnemius of the right leg prior to entering the chamber during the baseline 
and post testing visits and remained on for the duration of these visits. Specifically, the NIRS 
device was fitted 2/3 distance from the calcaneus and anterior fossa and secured with an 
elastic bandage (Tiger Tear, Hampshire, United Kingdom) to prevent movement and covered 
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with an optically dense black material to minimize the intrusion of extraneous light. The 
position of the probe was marked with indelible ink, which was reapplied at regular intervals 
during the intervention protocol to ensure correct placement of the optode during the post-
intervention trial. Changes in tissue oxyhemoglobin ([O2Hb]), [HHb] and total hemoglobin 
([tHb]) relative concentrations were measured (μM) using a spatially resolved spectrometer, 
measuring the differences in absorption characteristics of infrared light at 760 and 850 nm, 
with data acquisition of 10 Hz. Values for [HHb] and [tHb] were reported as the delta from 
baseline (30 s average prior to cycling stage) to the final 30 s of the steady state trial 
(∆[HHB]ss and ∆[tHB]ss, respectively) and between the end of the steady state trial to the end 
of the incremental ramp test (∆[HHB]inc and ∆[tHB]inc, respectively) to examine the local 
muscle metabolic demands of the exercise bout.  
 
Resting limb blood flow (LBF) was measured to identify muscle microvascular blood flow in 
response to the severe hypoxic environment, immediately prior to the rest-to-exercise 
transition. This was intended to evaluate the rested state of the muscle microvasculature when 
exposed to a severe hypoxic stimulus, in the period closest to the exercise transition, which 
we hypothesized could have been affected by the IPC intervention. Subjects entered the 
chamber and lay supine for 5 min on a massage table, with a rapidly inflating blood pressure 
cuff fitted around the mid-thigh of the right leg (width: 15 cm; Hokanson SC12D, Bellevue, 
WA, United States). The cuff was connected to a rapid cuff inflator (E20, Hokanson, 
Bellevue, WA, United States) and supplied by an air compressor. Resting limb blood flow 
was assessed by rapidly occluding the pressure cuff to 50 mm Hg for 10 s on 2 occasions, 
each separated by 2 min. Blood flow was determined according to a previous study, whereby 
a technique for measurement of local muscle O2 consumption and forearm blood flow in 




Following LBF assessment, the subjects rested in the chamber on the ergometer (SRM 
Ergometer, Schoberer Rad Meßtechnik, Jülich, Germany) for ~ 10 min prior to each exercise 
bout, where they were fitted with a face mask, which supported a turbine volume transducer 
and gas sampling lines for breath-by-breath measurements of gas flow rates and fractions (O2 
and CO2), respectively. All measurements were performed on a pulmonary gas analyzer 
(Jaeger Vyntus CPX, Hoechberg, Germany). Pulmonary V O2 (V O2p), V CO2 and respiratory 
exchange ratio, minute ventilation (V E) and oxygen pulse (O2pulse; mL V O2 /heart beat) were 
recorded for 2 min prior to exercise onset, alongside resting [HHB] and [tHB]. Subjects then 
transitioned from rest to moderate intensity exercise (external power output = 100 W, < 
hypoxic gas exchange threshold [GET]) for a 10 min period on the electromagnetically 
braked cycle ergometer at their a-priori fixed self-selected cadence, which was 80 rev∙min-1 
for all subjects. Heart rate (HR; Polar FT1, Polar Electro Oy, Kempele, Finland), arterial 
oxygen saturation (SpO2 %; Vyntus CPX; CareFusion; Hochberg, Germany) were recorded 
continuously and reported as the mean of the steady state 10 min exercise bout and during the 
final 30 s of the ramp protocol (peak SpO2).   
 
The V O2p data were initially inspected, with aberrant data points (4 SD of the local mean) 
removed. These data were then linearly interpolated to 1 s intervals and time aligned, such 
that V O2p on-kinetics could be modelled from the start of the constant load exercise. 
Following baseline correction, V O2p on-kinetics were modelled using a non-linear least 
squares fitting procedure (Graphpad Prism, Graphpad Software, San Diego, CA). After 
excluding the first 20 s of data on-transients (ie. phase I 34), a mono-exponential model was 





) = V O + V O (1 − 
(
)/)                (equation 1) 
 
where V O (
) = absolute ̇V O at a given time t; V O = 2 min baseline resting ̇V O2;  = 
fundamental (phase II) time constant; TD = phase II time delay and V O = ̇V O 
amplitude (ie. ΔV O > V O). The data were modelled from 0 s to 240 s, where steady 
state V O (V O) was achieved. 
 
The [HHB] derived from the NIRS device was averaged to reduce from 0.1 s to 1 s values 
and time aligned with the V O2p on-transient data, such that the start of the constant load 
exercise = 0 s. The time delay for the [HHb] response (TD [HHb]) was determined as the 
time (s) between the onset of exercise and the point of continual rise above the nadir value. 
The [HHb] data were modelled using the same mono-exponential curve (equation 1) across 
0-120 s of exercise, where steady state was achieved ([HHB]SS). 39 The TD [HHB] was 
included in the model and baseline [HHb] ([HHb]Base) was determined from the 2 min pre-
exercise resting period. 
 
To evaluate the matching of O2 delivery and utilization, the corrected V O2p and [HHb] data 
were normalized relative to their steady state values (ie. % of steady state) and time aligned, 
such that the start of phase II V O2p kinetics (ie. 20 s) matched the 0 s of [HHB] exercise 
onset. The normalized data were then averaged into 5 s epochs, with the [HHb]:V O2p ratio 
calculated in series. The mean value from 20 s to 120 s of the exercise transition was 
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calculated and used to represent the overall O2 delivery to utilization ratio, 39 where a value of 
1.0 represents equal matching and >1.0 indicate mismatching in favour of ‘extraction’. 
 
Continuous ramp test (10 W∙min-1) transition was performed until exhaustion, where time to 
exhaustion (TTE; min) was determined. Pulmonary V O2max was determined as the mean value 
recorded over the final 30 s of the test. Criteria for achieving V O2max was: [1] reaching 
volitional exhaustion [2] respiratory exchange ratio > 1.15 and [3] rating of perceived 
exertion >19 on a 6-20 scale. Breath-by-breath V O2 and V CO2 data from the incremental 
cycling test was used to plot GET using the simplified v-slope method 37 and evaluation of 
ventilatory equivalents. 36 
 
During the baseline and post test steady state trials, the subjects gross efficiency (GE %) was 
determined as the ratio of work rate accomplished (kcal∙min-1) to energy expended (kcal∙min-
1). Work rate accomplished was determined as mechanical power (W) × 0.01433. Energy 
expenditure was calculated from the 2 min respiratory collection between the fourth and sixth 
min of the 10 min steady state exercise using V̇O2 and respiratory exchange ratio. The 
calorific equivalent of O2 was then determined from the corresponding RER value. 35 Delta 
efficiency (DE) was determined between the GET and end of the incremental test, as 
previously reported. 34 Specifically, DE was determined as the ratio of the change in work 
accomplished/min to the change in metabolic energy expended/min between the VT and end 
of the incremental test 34. This was calculated from linear regression (y = ax + b) of energy 
expended/min (y, in kcal/min) and work accomplished/min (x, in kcal/min), where DE is 




The subjects lay in a supine position, with automatic inflation cuffs (14.5 cm width, Delfi 
Medical Innovations, Vancover, Canada) fitted to the proximal portion of both thighs. In the 
IPC group, the inflatable cuffs were automatically inflated to the subjects individual limb 
occlusive pressure, thus ensuring full arterial occlusion. Limb occlusive pressure is 
automatically recognized by the device, based on the identification of a pulse at each 
increment of occlusive pressure. When no pulse is consistently recognized, the associated 
pressure is determined as the LOP by the device. The LOP (mean±SD) of the IPC group was 
217±30 mm Hg. The IPC and SHAM protocols were repeated for 7 consecutive days, as 
reported previously. 20 Specifically, the legs were occluded for 5 min, followed by 5 min 
reperfusion, which was repeated 4 times (lasting 40 min) in the supine position. The SHAM 
group were told that they would be receiving the IPC intervention but experienced a lower 
pressure (20 mm Hg) using the same automatic inflation cuffs. The sum of 8 skinfolds was 
measured as an indication of whole-body adipose tissue thickness. These included: biceps, 
triceps, subscapular, iliac crest, supraspinale, abdominal, front thigh and an adapted calf 
measurement at the site of the NIRS optode. Measurements were recorded in duplicate, to the 
nearest 0.1 mm using skinfold calipers (Harpenden, Burgess Hill, UK). The skin and 
subcutaneous tissue thickness values (mean±SD) for the IPC and SHAM group’s calf sites 
was 9±2 mm and 8±2 mm, respectively. This was less than half the distance between source 
and the detector (35 mm). 
 
Statistical analysis 
Changes in all steady state and incremental test variables and both V O2 and [HHB] on-kinetic 
profiles were analyzed using 2-way (group [IPC vs Sham] x time [pre vs post]) within and 
between analyses of variance. Where relevant, assumptions of sphericity were assessed using 
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Mauchly’s test, with any violations adjusted using the Greenhouse-Geisser correction. When 
significant F-values were observed, Bonferroni post-hoc tests were used to determine 
differences. Statistical significance was accepted at P < 0.05 for all tests and all analyses 
were performed on IBM SPSS Statistics (Version 21, IBM Corp., Armonk, NY, USA). 
 
Results 
There were no group x time interactions for TTE (F(1,12) = 1.883, P = 0.195; Figure 2A), peak 
SpO2 (F(1,12) = 1.336, P = 0.270; Figure 2B) or V O2max (F(1,12) = 0.021, P = 0.887; Figure 2C) 
during the ramp test, nor were main effects of group or time observed for V O2max, TTE or 
peak SpO2 (P > 0.05). 
 
***Insert fig 2 here*** 
 
As presented in Table II, there were no group x time interactions for steady state HR (F(1,12) = 
0.010, P = 0.921) or peak HR (F(1,12) = 0.027, P = 0.872), steady state O2pulse (F(1,12) = 0.155, 
P = 0.701) or peak O2pulse (F(1,12) = 0.174, P = 0.684). No main effects of group or time were 
observed for any HR or O2pulse variable (P > 0.05). Similarly, there was also no group x 
time interaction for steady state SpO2 (F(1,12) = 3.961, P = 0.070), nor were there main group 
or time effects (P > 0.05). There were no interaction effects (F(1,12) = 2.593, P = 0.133) or 
main effects of time or group for steady state V E (P > 0.05). Similarly, there were no group x 
time interaction (F(1,12) = 0.013, P = 0.932) or time effects (P > 0.05) but there was group 
effects (F(1,12) = 4.922, P = 0.047) for V E measured in the final 30 s of the incremental tests, 




There were no significant interactions for GE (F(1,12) = 2.366, P = 0.150) or main effects (P > 
0.05); however, there were main effects of group (F(1,12) = 10.757, P = 0.007) and time (F(1,12) 
= 7.188, P = 0.020) for DE but no interactions were found (P > 0.05). To clarify the reasons 
for the main effects, in the absence of interactions with time, Bonferroni pairwise 
comparisons were conducted on the pre to post differences in DE within each group. The IPC 
group increased DE pre to post intervention (P = 0.011), while there were no differences pre 
to post SHAM intervention (P = 0.436). There were no interactions (F(1,12) = 2.764, P = 
0.122) or main effects (P > 0.05) for GET (Table II). There were time (F(1,12) = 34.231, P < 
0.001) and group effects (F(1,12) = 4.184, P = 0.045) only for resting LBF, with higher values 
in the IPC group compared to SHAM with pre and post intervention values pooled (0.4±0.2 
mL∙100 mg-1∙min-1 vs. 0.3±0.1 mL∙100 mg-1∙min-1, respectively). The LBF results for the IPC 
group pre and post intervention were 0.3±0.1 and 0.5±0.2 mL∙100 mg-1∙min-1, respectively; 
while the SHAM groups’ pre and post intervention results were 0.2±0.1 and 0.4±0.1 mL∙100 
mg-1∙min-1, respectively. 
 
***Insert Table II here ***  
 
As presented in Table III, there were group x time interactions for ∆[HHB]ss (F(1,12) = 7.042, P 
= 0.042), with post-hoc tests demonstrating lower values (P = 0.001) in the post tests 
compared to pre testing in the IPC group but not SHAM (P = 0.180). There were no between-
group differences at pre or post testing (P > 0.05). The change in [HHB] between the end of 
the steady state and the end of the ramp test (∆[HHB]inc) did not demonstrate group x time 
interactions (F(1,12) = 0.720, P = 0.416) but did have group main effects (F(1,12) = 5.917, P = 
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0.035), with lower values in the IPC group. There were no interactions or main effects found 
for ∆[tHB] during any of the tests (P > 0.05). 
 
The V O2p and [HHB] kinetics parameters are presented in Table III. There were no group x 
time interactions for V O2p (F(1,12) = 3.359, P = 0.092), TD V O2p (F(1,12) = 1.689, P = 0.218), 
V O2pBase (F(1,12) = 1.951, P = 0.188), V O2pAmp (F(1,12) = 0.034, P = 0.858), V O2pSS (F(1,12) = 
2.509, P = 0.139). There was a group x time interaction for [HHB] (F(1,12) = 5.660, P = 
0.045), with post-hoc tests revealing slower on-kinetics from pre to post testing in the IPC 
group (P = 0.023) but there were no changes in the SHAM group (P = 0.818). However, there 
were no interactions for TD [HHB] (F(1,12) = 0.187, P = 0.675), [HHB]Base (F(1,12) = 0.248, P = 
0.629), [HHB]Amp (F(1,12) = 0.041, P = 0.844) and [HHB]SS (F(1,12) = 0.188, P = 0.674). There 
were no group or main effects for all V O2p and [HHB] on-kinetics parameters (P > 0.05). The 
group x time interactions for [HHB]:V O2p (F(1,12) = 9.086, P = 0.013) were the result of 
reductions from pre to post testing among the IPC group only (P < 0.001). There were also 
lower values in the IPC group compared to SHAM at post testing for [HHB]:V O2p (P = 
0.027). Representative traces of the [HHB]:V O2p (panel A) and the corresponding [HHB] 
(panel B) and V O2p on-kinetics (panel C) are shown in Figure 3. Figure 4 presents a 
representative trace of the normalized [HHB] and V O2p before (panel B) and after (panel A) 
the IPC intervention.  
 
***Insert fig 3 and 4 here *** 





Seven days of IPC increased DE during the incremental test and reduced ∆[HHB] (reduced 
O2 extraction) of the gastrocnemius compared to the SHAM group across the steady state 
test. The IPC intervention also reduced the overshoot in [HHB]:V O2p ratio during exercise 
onset that was present at baseline among all subjects in severe hypoxia, whereas SHAM did 
not. Despite this, repeated IPC did not improve V O2max or TTE in severe hypoxia. Similarly, 
there was no effect on GE during the moderate domain exercise trials, nor was there an 
alteration in the GET. The effects on DE, ∆[HHB] and [HHB]:V O2p ratio appeared to be 
underpinned by an increased limb blood flow, alongside a significant slowing of the [HHB] 
on-transient kinetics, coupled with a modest speeding of the V O2p on-kinetics (although non-
significant) in the IPC group. Why these seemingly favourable changes to the muscle-
metabolic milieu did not confer any effects on V O2max or exercise tolerance requires further 
consideration. 
 
Repeated application of IPC across 7 d can improve DE in normoxia, alongside reductions in 
∆[HHB] during steady state exercise < GET, without improving V O2max. 19 We reaffirm these 
findings in severe hypoxia but in contrast to these previous reports 19 there was no increase in 
TTE in the current study, despite performing an almost identical incremental test protocol. It 
is possible that the environmental constraints inhibited the commonly reported ergogenic 
effect of repeated IPC on exercise tolerance. Such is the severity of exercising in 0.103 FiO2, 
it is possible that reduced cerebral O2 availability and cortical voluntary activation explained 
the inability (or reluctance) to continue exercise 13, despite the improved DE and prior 
reductions in submaximal muscle O2 extraction found here. Of interest, there was no effect of 
the IPC intervention on ∆[HHB] measured between the end of steady state and end of the 
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incremental test, indicating that no additional O2 extraction ‘reserve’ was utilized during the 
transition to maximal exercise. 18 Thus, in severe hypoxia, submaximal physiological 
responses appear to be those most affected by repeated IPC. 
 
The only other study to investigate the effect of repeated IPC (5 d) on exercise performance 
in a hypoxic environment (outdoor altitude of 4342 m; inspired air ~ 142 mm Hg) reported ~ 
7% improvements in the time to complete a 12.8 km run compared to placebo. 10 Foster and 
colleagues also observed concurrent improvements in SpO2% (> 5%), which was not found 
in the present study. In addition, there were no changes in maximal or steady state HR, V E or 
V O2p. Collectively, our results indicate that the presumed effect of repeated IPC on 
pulmonary ventilation (or exercise tolerance) 10 are unlikely to transfer to the simulated 
(normobaric) hypoxic environment used in the current study. This could be related to 
previous study designs, where a sufficient period of time without IPC was not provided, as to 
avoid acute effects on performance. 10 The lack of change in these selected cardio-pulmonary 
variables likely explains the null effect of IPC on V O2max found here, which is thought to be 
primarily limited by such factors. 2 The above interpretations concur with reports at lower 
simulated altitudes following acute IPC interventions (FiO2 = 0.162; 43) and infer that the 
effects of repeated IPC must be realized in other tissues, perhaps more local to the site of 
interrogation (ie. skeletal muscle  19, 20). 
 
We have demonstrated improved matching of microvascular O2 delivery to utilization via the 
diminished [HHB]:V O2p overshoot (~ 0.06) following the IPC intervention during the rest-to-
exercise transition. Owing to the environmental constraints imposed in hypoxic 
environments, which reduces alveolar O2 tension (PaO2) and perturbs O2 distribution, the 
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overshoot is pronounced during exercise onsets in hypoxia. 39, 46 This is indicative of an 
increased reliance on O2 extraction for a given V O2p, inferring a mismatch downstream from 
the conduit artery between the microvascular O2 distribution and O2 utilization. 32 The 
overshoot magnitude strongly correlates with V O2p when on-kinetics are > 20 s ‘O2-
dependent’ threshold, 32, 39 indicating a delayed metabolic control during exercise. Three 
weeks of endurance training can diminish the overshoot by a larger magnitude (0.10 to 0.15) 
and concurrently reduce the V O2p in young and elderly populations, 31 which is interesting in 
comparison to the current observations, since these were induced after 7 d of passive 
intervention. In respect to the hypoxic environment, the larger (slower) [HHB] found after 
IPC is likely to be related to increased microvascular blood distribution at the site of 
interrogation. 45 Thus, conversely, the pre intervention overshoot found in all subjects in 
hypoxia could relate to limb blood flow impairments. The changes post IPC could have 
partially offset these deficits and corrected the delivery-utilization mismatch.  
 
Heavy-intensity priming exercise has also been reported to elicit similar effects on the 
transient relationship between [HHB] and V O2p in both normoxic 14 and hypoxic 
environments, 39 by speeding V O2p kinetics and enhancing the dynamic matching of muscle 
O2 extraction and utilization. A 0.06 normalized reduction in the overshoot was reported, 
which is the same as the magnitude found following repeated IPC in the current study. These 
effects were ascribed to the increased microvascular blood distribution (rather than bulk flow) 
observed following heavy priming exercise. 39 It is, therefore, our assumption that the 
increased resting local blood flow measured during severe hypoxia exposure, which perhaps 
overcomes the presumed pre exercise reduction in limb blood flow pre exercise 15, translated 
to the subsequent exercise transition and supported the observed delivery-utilization 
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matching. Whilst the post IPC V O2p and V O2Amp were not appreciably different than the pre 
IPC testing, the subsequent transition to incremental exercise led to improved DE, which 
indirectly evaluates muscle metabolic efficiency. 27 This might explain why DE, but not GE, 
was improved after the IPC intervention, as reported previously. 19 The observed adaptations 
would be beneficial for prolonged, lower intensity exercise tolerance, such as those often 
performed in high altitude. 28, 38 
 
The single transitions used in this study to describe the V O2p on-kinetics may have limited the 
capacity to identify changes in phase II time constant. 1 Regardless, these limitations did not 
prevent identification of reductions in the overshoot of [HHB]:V O2p ratio, and changes in 
∆[HHb] were also found following the intervention. Secondly, while the techniques used for 
the IPC and SHAM groups in the current study were typical and subjects were naïve to the 
intervention, it does not rule out the possibility that the subjects understood the nature of their 
allocated grouping and subsequent placebo (IPC) effects were present, particularly for 
voluntary exercise aspects of the study. Similarly, as these subjects were not familiarized to 
the specific procedures for this study, it is possible that their exercise tolerance was 
underestimated; however, they all had the same familiarity with laboratory exercise prior to 
the study. Thirdly, it is possible that the subjects’ level of fitness could have confounded the 
effect of the IPC, given the preliminary evidence that those of higher endurance fitness have 
been reported to respond to IPC more than less trained 5, 29 but this requires further 
investigation in repeated IPC applications. Lastly, while the current sample provided 
sufficient power to detect the anticipated changes in the main outcome variable (∆[HHb]), it 
is possible that other variables evaluated here were not equally powered. For example, post-
hoc power analysis of DE demonstrates that the interaction effects yielded a 1- of 0.49 and, 




While 7 d of lower-limb ischemic preconditioning did not improve shorter-term exercise 
capacity or V O2max in severe hypoxia, it did positively affect a number of submaximal 
variables, including reductions in muscle microvascular O2 extraction and increased control 
(matching) of the O2 delivery-utilization relationship during exercise onset. Limb blood flow 
and slowing of the [HHB] on-transient kinetics might explain these effects but require further 
investigation. Therefore, those exercising at lower intensities in severe hypoxia could benefit 
from the improved muscle O2 efficiency caused by repeated IPC, especially if longer-term 
exercise bouts are undertaken in severe hypoxic conditions. Improved exercising muscle 
efficiency and matching of muscle O2 delivery-utilization during exercise onset, alongside 
reduced metabolic O2 demand during steady state exercise, could delay fatigue and improve 
exercise tolerance during prolonged moderate intensity exercise; however, further 
investigations are needed to confirm this and corroborate these preliminary data.    
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Table I. Baseline participant characteristics of the ischemic preconditioning and SHAM groups.     
  IPC (n = 7) SHAM (n = 7) 
Body mass (kg) 86.0 ± 13.3 80.1 ± 10.8 
Stature (cm) 181 ± 7 181 ± 9 
Sum of 8 skinfolds (mm) 81 ± 6 79 ± 16 
Age (y) 27 ± 3 26 ± 4 
Baseline V O2max (mL∙kg-1∙min-1) 32.2 ± 2.9 30.8 ± 3.0 
Note: t-tests demonstrated no differences between groups for any variable (P > 0.05).  
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Table II. Heart rate (HR), oxygen pulse (O2pulse), mean arterial oxygen saturation (SpO2) gross efficiency (GE), minute ventilation (V E) delta 
efficiency (DE) and gas exchange threshold (GET) during steady state and incremental exercise (mean ± SD), pre and post ischemic 
preconditioning (IPC) or SHAM interventions. 
  Pre   Post 
  IPC (n = 7) SHAM (n = 7)  IPC (n = 7) SHAM (n = 7) 
Steady state 
             
Mean HR (beats∙min-1) 133 ± 13 147 ± 12 
 
131 ± 15 145 ± 14 
Mean O2pulse (mL∙beat-1) 14 ± 1 12 ± 2 
 
14 ± 1 13 ± 2 
GE (%) 16 ± 1 17 ± 3 
 
16 ± 1 16 ± 1 
SpO2 (%) 68 ± 3 72 ± 5 
 
71 ± 4 71 ± 6 
V E (L∙min-1) 46.7 ± 5.9 50.4 ± 6.9  48.1 ± 4.7 48.3 ± 5.5 
Incremental test 
             
Peak HR (beats∙min-1) 173 ± 8 175 ± 12 
 
170 ± 9 174 ± 12 
Peak O2pulse (mL∙beat-1) 16 ± 3 14 ± 2 
 
16 ± 3 14 ± 2 
GET (%) 73 ± 6 73 ± 8 
 
77 ± 6 73 ± 7 
DE (%) a,b 34 ± 2 31 ± 2 
 
39 ± 6 32 ± 3 
V E (L∙min-1) a  113.4 ± 23.7 99.1 ± 12.9  113.4 ± 25.4 100.7 ± 17.4 
 Note: a = main effect of group; b = main effect of time (P < 0.05). 
 
 
Table III. The deoxyhemoglobin concentration [HHb] and pulmonary oxygen uptake responses (V O2p) from rest to moderate exercise (mean±SD), 
pre and post ischemic preconditioning (IPC) or SHAM interventions. 
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  Pre   Post 
      IPC (n = 7) SHAM (n = 7)     IPC (n = 7) SHAM (n = 7) 
Pulmonary measures 
             
V O2pBase (mL) 680 ± 220 583 ± 118 
 
556 ± 216 694 ± 98 
V O2pAmp (mL) 1237 ± 122 1139 ± 190 
 
1271 ± 250 1156 ± 135 
V O2pSS (mL) 1917 ± 267 1723 ± 279 
 
1827 ± 100 1850 ± 155 
V O2p (s) 28.5 ± 4.5 28.3 ± 3.6 
 
23.5 ± 2.4 29.0 ± 7.1 
TD V O2p (s) 15.1 ± 5.1 11.3 ± 4.2 
 
14.5 ± 3.4 16.2 ± 6.1 
Microvascular measures       
 
      
[HHB]Base (μM) 4.8 ± 2.8 2.9 ± 2.4 
 
5.8 ± 3.2 3.4 ± 2.2 
[HHB]Amp (μM) 15.8 ± 5.3 18.2 ± 8.2 
 
14.0 ± 4.2 17.3 ± 8.9 
[HHB]SS (μM) 18.8 ± 2.9 24.7 ± 9.2 
 
17.8 ± 3.1 26.3 ± 14.1 
[HHB] (s) c 8.8 ± 3.4* 8.6 ± 3.5 
 
11.7 ± 5.3 8.4 ± 2.5 
TD [HHB] (s) 4.8 ± 2.8 2.9 ± 2.4 
 
5.9 ± 3.2 3.4 ± 2.1 
[HHB] : V O2p c 1.10 ± 0.04* 1.11 ± 0.02 
 
1.04 ± 0.05 1.09 ± 0.02† 
∆[HHB]ss a,b,c 17.3 ± 5.3* 18.8 ± 3.3 
 
14.0 ± 4.9 17.8 ± 3.9 
∆[HHB]inc  a 5.9 ± 1.2 4.8 ± 1.2 
 
5.8 ± 2.2 3.7 ± 1.4 
∆[tHB]ss 2.9 ± 2.8 3.8 ± 1.5 
 
4.5 ± 2.1 3.2 ± 0.7 
∆[tHB]inc 4.5 ± 3.5 4.3 ± 2.4 
 
3.6 ± 2.1 4.5 ± 1.1 
Note: a = main effect of group; b = main effect of time; c = interaction effect (P < 0.05).* = different from post-test comparison of that group (P < 0.05); † = different from 
IPC at post test. All measurements of muscle microvascular relative concentrations were measured (μM) using a spatially resolved spectrometer. Delta values, 








Figure 1. Schematic diagram of the experimental timeline. Screening included written 
informed consent of subjects and body composition analysis. Visits 1 and 9 included resting 
limb blood flow and cycling assessment, comprising a steady state cycling assessment at 100 
W and step test to exhaustion at 10 W increments. Visits 2-8: Group A = ischemic 
preconditioning (IPC) at 100% limb occlusive pressure; Group B = SHAM at 20 mm Hg. IPC 
administration = IPC of the lower extremities consisted of 5 min occlusion, followed by 5 






Figure 2. Maximal oxygen consumption (V O2max), time to exhaustion (TTE) and final arterial 
oxygen saturation (SpO2 %) during the incremental ramp test (mean±SD) pre and post 








Figure 3. Representative traces of the deoxyhemoglobin to pulmonary oxygen uptake ratio 
([HHB]:V O2p) (panel A) and the corresponding [HHB] (panel B) and V O2p on-kinetics (panel 
C) during the rest to moderate exercise transition in a subject in the ischemic preconditioning 





Figure 4. Representative traces of the normalized pulmonary oxygen uptake (V O2p) and 
deoxyhemoglobin ([HHB]) pre (panel A) and post (panel B) in a subject in the ischemic 
preconditioning (IPC). Data are presented in 10 s intervals. Error bars are SD. 
